Handelsbanken Fonder AB JANX — JANUX THERAPEUTICS INC COM

Ownership history in Handelsbanken Fonder AB  ·  6 quarters on record

AI Ownership Summary

Handelsbanken Fonder AB reported JANUX THERAPEUTICS INC COM (JANX) in 6 quarterly 13F filings from 2024 Q4 through 2026 Q1. The latest visible filing shows JANX at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this JANX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Handelsbanken Fonder AB's position in JANUX THERAPEUTICS INC COM, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

JANX was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

JANX stock page Handelsbanken Fonder AB fund profile Handelsbanken Fonder AB full holdings
How Handelsbanken Fonder AB held JANX — position size vs. price
% of Fund (quarterly)    JANX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 17,800 — 0% 0.00% $247 2026-04-28 $14.50
2025 Q4 ADDED — — — 17,800 +3,800 +27.1% 0.00% $246K 2026-02-06 $13.07
2025 Q3 UNCHANGED — — — 14,000 — 0% 0.00% $342K 2025-11-12 $28.52
2025 Q2 ADDED — — — 14,000 +2,000 +16.7% 0.00% $323K 2025-08-12 $24.27
2025 Q1 UNCHANGED — — — 12,000 — 0% 0.00% $324K 2025-04-15 $29.06
2024 Q4 INITIATED — — — 12,000 — — 0.00% $642K 2025-02-03 $42.07

🏢 Other funds also holding JANX

As of 2026 Q3 — sorted by position size

CONGRESS ASSET MANAGEMENT CO 3Y 7Y 0.01% Versant Capital Management, Inc 3Y 7Y 0.01%

FAQ About Handelsbanken Fonder AB and JANX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Handelsbanken Fonder AB reported owning JANX?

Handelsbanken Fonder AB reported JANX across 6 quarterly 13F filings, from 2024 Q4 through 2026 Q1.

What was the largest reported JANX position in Handelsbanken Fonder AB's portfolio?

The largest reported portfolio weight for JANX was 0.00% in 2024 Q4.

What is the latest reported JANX position on this page?

The most recent filing on this page is 2026 Q1, when Handelsbanken Fonder AB reported 17,800 shares, equal to 0.00% of portfolio, with an estimated market value of $247.

What does the chart on this JANX ownership page compare?

The chart compares Handelsbanken Fonder AB's quarterly JANX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Handelsbanken Fonder AB time their JANX position?

Based on 13F filing dates vs. subsequent JANX price moves, Handelsbanken Fonder AB correctly timed 2 out of 3 reported position changes (67%). The annualised alpha on JANX relative to SPY over the holding period was -63.9%.

← Back to Handelsbanken Fonder AB Holdings